Treatment of hypertension and dyslipidemia or their combination among US managed-care patients.

Michael P. Dutro, Tracey D. Gerthoffer, Eric D. Peterson, Simon S.K. Tang, George A. Goldberg

Research output: Contribution to journalArticlepeer-review

13 Scopus citations


The authors examined treatment rates in managed-care patients with hypertension (HTN) only or dyslipidemia (DYS) only compared with patients who had both (HTN+DYS). A retrospective, cross-sectional claims analysis was performed in a 2002 US national managed-care database of 1.23 million continuously eligible members aged 18 years or older. Median age was 44.0 years, 8.8% were aged 65 years or older, and 53.2% were women. Study criteria identified 354,324 patients, 32.9% with HTN only, 34.7% with DYS only, and 32.4% with HTN+DYS. Overall, 49.7% of HTN patients had DYS and 48.3% of DYS patients had HTN. Patients with HTN+DYS were significantly older, more likely to have cardiovascular comorbidities, and more likely to use medications and hospital facilities than were patients with HTN only or DYS only (P<.01). About two-thirds of patients with HTN only received 1 or more prescription for an antihypertensive medication, compared with three-quarters of those with HTN+DYS. Fewer than half of patients with DYS only and approximately two-thirds with HTN+DYS received a cholesterol-lowering agent.

Original languageEnglish (US)
Pages (from-to)684-691
Number of pages8
JournalJournal of clinical hypertension (Greenwich, Conn.)
Issue number9
StatePublished - Sep 2007
Externally publishedYes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Treatment of hypertension and dyslipidemia or their combination among US managed-care patients.'. Together they form a unique fingerprint.

Cite this